Participation in the BCCS protocol involves significant risks including but not limited to: smart contract vulnerability, regulatory changes, protocol failure, network attacks, loss of private keys, and total loss of funds. The BCCS verification unit may have zero value. Past performance of similar protocols does not indicate future results. Do not participate with funds you cannot afford to lose.
BCCS smart contracts are deployed on Base Layer 2 and built using OpenZeppelin audited libraries. However, contracts may contain undiscovered vulnerabilities. Professional security audit mitigates but does not eliminate this risk. Funds locked in contracts, including staking deposits and treasury holdings, are at risk if exploited. There is no guarantee that all vulnerabilities will be identified or resolved.
KRYONIS Sovereign Systems Limited operates under the laws of Hong Kong SAR. The regulatory framework for digital assets in Hong Kong and globally is evolving. Current analysis suggests that $BCCS qualifies under the SFC utility token exemption, but regulatory interpretations may change. The VA dealing licensing regime is being legislated in 2026 and may affect operations. Regulatory actions in any jurisdiction could restrict or prohibit BCCS operations or participation.
The BCCS verification unit ($BCCS) may have zero value. There is no guarantee of demand for verification queries. The biological verification market may not develop as projected. Competing protocols may emerge. Market conditions may change adversely. KRYONIS makes no representations regarding the future value of $BCCS.
The BCCS verification model requires validators, data consumers, and institutional partners to function. Failure to attract sufficient participants in any of these categories would prevent protocol operation or significantly reduce its utility. There is no guarantee that the protocol will achieve the adoption necessary for sustainable operation.
Despite multi-source verification and economic slashing penalties, determined adversaries may attempt to submit false biological state data through collusion or sensor manipulation. The economic cost of attack, represented by staking requirements, provides resistance but not immunity. Verification data quality depends on the integrity of participating validators.
In the current phase, the BCCS protocol depends on a single founder. If the founder becomes incapacitated or ceases development work, protocol development may halt. Mitigation measures include multisig wallet recovery capabilities, publicly verifiable open-source code, and pre-defined governance transition criteria. However, these mitigations do not eliminate the dependency risk.
Base Layer 2 depends on Ethereum Layer 1 for settlement finality. Ethereum or Base network disruptions, sequencer centralization, bridge vulnerabilities, and EVM compatibility changes are all risk vectors that could affect BCCS operations. The protocol inherits all risks associated with the underlying blockchain infrastructure.
Other protocols may build biological verification infrastructure. DePIN protocols with larger treasuries, more established communities, or stronger institutional backing may enter the biological verification space. There is no guarantee that BCCS will maintain any competitive advantage.
Holding an Infrastructure Access License does not guarantee any income, return, or financial benefit. Validator emissions begin only when the mainnet verification network is operational and require active work. The amount of protocol emissions received, if any, depends on network conditions, participation levels, and protocol parameters that may change.
Loss of private keys to your wallet results in permanent, irreversible loss of access to your Infrastructure Access License and any associated digital assets. KRYONIS cannot recover lost keys or reverse blockchain transactions.
This Risk Disclosure is not exhaustive. Additional risks may exist that are not currently foreseeable. Participants should carefully evaluate their personal circumstances and risk tolerance before engaging with the BCCS protocol. Independent legal and financial advice is strongly recommended.